A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3019 Capsule in Subjects With Advanced Malignant Tumors

NCT06943677 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Cancer

Interventions

DRUG: TQB3019 capsules

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.